As we age, it becomes increasingly difficult to determine who will maintain their vitality and who is at risk of a sharp decline in health. A recent study by scientists from Duke Health<\/b> and the University of Minnesota<\/b>, published in the journal Aging Cell<\/i>, suggests that the answer may lie in our blood.<\/p>\n
Researchers have discovered that small RNA molecules called piRNAs<\/b> can predict with high accuracy whether an older adult will survive for at least another two years.<\/p>\nWhat Does the Study Say?<\/h3>\n
As part of the study, scientists examined blood samples from more than 1,200 individuals aged 71 and older. Using Artificial Intelligence and Machine Learning<\/b>, they analyzed 187 clinical factors and 828 different types of small RNAs.<\/p>\n
The results showed that a group consisting of just six specific piRNAs predicted two-year survival chances with 86% accuracy<\/b>. Interestingly, this biological signal proved to be a much stronger predictive indicator than the patient’s age, cholesterol levels, or physical activity.<\/p>\n
According to the researchers’ observations, participants who lived longer exhibited lower levels of piRNAs. This pattern echoes a principle already observed in simpler organisms, where a reduction in the number of these molecules increases lifespan.<\/p>\n
The study’s authors explain that a high concentration of piRNAs in the blood may be a signal that something is disrupted in the body’s functioning, which opens the door to discovering new therapeutic opportunities in the future.<\/p>\n
piRNAs act as a kind of “micromanager”<\/b> in the body, controlling many processes responsible for health and aging. While lifestyle remains a decisive factor in the long term, these molecules provide unrivaled information for assessing short-term viability. Through them, it is possible to see hidden biological processes that are invisible to traditional clinical examinations.<\/p>\n
The next step for scientists will be to determine how specific medications or lifestyle changes affect piRNA levels. The ultimate goal is to create a practical and minimally invasive blood test<\/b> that will help doctors identify the risk of health deterioration at an early stage.<\/p>\n